According to Emergen Research, the global bioreactors market size was USD 1,407.6 million in 2021 and is expected to reach USD 2,482.5 Million in 2030 and register a steady revenue CAGR of 6.5 % during the forecast period, 2022-2030. The rising prevalence of chronic diseases, increasing investment to accelerate drug and vaccine development, and rapid adoption of technologically improved bioreactors are some key factors expected to drive Bioreactors market growth.
Bioreactors are manufacturing vessels or tanks in which microorganisms or cell-free enzymes are used for transforming raw materials into biochemical products. Bioreactors are also used for performing biological reactions and producing yeast, animal cells, and bacteria in a controlled environment for commercial purposes. Diagnostic products based on enzymatic reactions, farm silos for silage fermentations, bread pans with fermenting yeast, and the soil in a Kansas wheat field may also be viewed as bioreactors. Simple or highly instrumented bioreactors are used for the production of desired products that have various agricultural, environmental, industrial, and medical applications.
Demand for biologic drugs, antibodies, preventive vaccines, and effective treatment therapeutics is increasing owing to the rising prevalence of chronic disease, and is expected to boost the sale of clinical-stage bioreactors and contribute to market revenue growth over the forecast period. In addition, the development of technologically advanced bioreactors having high quality, scalability, and flexibility of operations requiring low capital and energy requirements is leading to an increase in the commercial production of products. The incorporation of novel approaches and analytical tools for improvement in robustness and accelerating scale-up to industrial production are leading to increased adoption of bioreactors in many research and academic institutions. Moreover, increasing applications of hybrid bioreactor technology in effective waste management is another factor expected to drive revenue growth of the market over the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- took a toll on the economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continues to cause concerns and impact normal routines
Single-use Segment Revenue Growth to Support Market Growth:
The single-use segment is expected to account for a significantly large revenue share in the global market over the forecast period. Properties of single-use bioreactors such as high sanitization, low contamination risk, and high control of aseptic conditions, among others are increasing their adoption across the globe. In addition, growing demand for biological drugs, rising research and development activities for vaccine production, and increasing government initiatives for the advancement of the pharmaceutical sector are some other factors expected to drive the demand for single-use bioreactors and fuel revenue growth of the segment over the forecast period.
Research and Development Segment Revenue to Expand Significantly:
The research and development segment is expected to register robust revenue CAGR over the forecast period attributable to the growing use of bioreactors in process development, manufacturing, and production of complex molecules such as proteins and nucleic acids, among others. The use of bioreactors that support high cell density and modern processes requiring high oxygen transfer and efficient carbon dioxide removal, among others, is leading to the expansion of biopharmaceutical manufacturing capacities and is expected to further drive revenue growth of the segment over the forecast period.
North America to Lead in Terms of Revenue Share:
North America is expected to account for the largest revenue share in the global market attributable to the increasing number of research facilities and advancements in academic institutions and growing government funding and initiatives to boost the pharmaceutical sector. In addition, growing focus on product innovation and rapid advancements in vaccine and drug development owing to the rising prevalence of chronic diseases are some other factors expected to drive revenue growth in the region.
Grab Your Free Sample Copy@ Bioreactors Market
Major Companies in the Market Include:
- Merck Group
- Getinge (Applikon Biotechnology)
- Eppendorf AG
- Sartorius Group
- Thermo Fisher Scientific.
For this report, Emergen Research has segmented the global bioreactors market based on the material type, end-use, and region:
Material Type Outlook (Revenue, USD Million; 2019-2030)
- Stainless steel
End-Use Outlook Revenue, USD Million; 2019-2030)
- Research and Development Department
- Research and Development Institutes
- Biopharmaceutical Manufacturers
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Contract Manufacturing Organizations (CMOS)
Regional Outlook (Revenue, USD Million; 2019-2030)
- North America
- the U.S.
- the U.K.
- Rest of Europe
- the Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa